Quantcast

Latest Postherpetic neuralgia Stories

2014-03-28 12:26:21

DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/qx6h7s/investigation) has announced the addition of the "Investigation Report on China Pregabalin Market, 2009-2018" [http://www.researchandmarkets.com/research/qx6h7s/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Neuropathic pain is caused by damage or pathological changes of nervous system. Its...

2014-03-24 08:29:56

Pivotal pharmacokinetic bridging clinical study anticipated to begin in May MALVERN, Pa., March 24, 2014 /PRNewswire/ -- Scilex Pharmaceuticals, Inc., a company engaged in the development and commercialization of products for the treatment of pain, today announced that it has filed an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration for its first product Ztilido(TM) (lidocaine patch 1.8%). The FDA Division of Anesthesia and Analgesia Products...

2014-03-21 08:25:35

Funds to be used for the clinical development of the Company's first product Ztilido(TM) (lidocaine patch 1.8%) MALVERN, Pa., March 21, 2014 /PRNewswire/ -- Scilex Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today announced that it has entered into definitive agreements for a private placement of common stock and warrants. The gross proceeds of the placement are expected to be approximately...

2014-03-10 16:33:25

NEWARK, Calif., March 10, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will release fourth quarter fiscal year 2013 financial results after the market closes on Wednesday, March 12, 2014. The Company will host a conference call beginning at 4:30 pm Eastern time, 1:30 pm Pacific time to discuss its results. Participants can access the call by dialing 877-317-6789 (United States) or 412-317-6789 (international). The conference call will also be available...

2014-03-05 16:26:21

NEWARK, Calif., March 05, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the 26th Annual ROTH Conference on Monday, March 10, 2014, at the Ritz Carlton in Dana Point, California. Depomed management is scheduled to present at 1:00 p.m. PT on Monday, March 10, with one-on-one meetings held throughout the day. A webcast of the presentation can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A...

2014-02-25 12:28:03

LONDON, Feb. 25, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:EpiCast Report: Postherpetic Neuralgia - Epidemiology Forecast to 2022EpiCast Report: Postherpetic Neuralgia - Epidemiology Forecast to 2022 SummaryPostherpetic Neuralgia (PHN) is one of the most common complications of herpes zoster infection in elderly persons ages 60 years and older, worldwide. The main symptom of PHN is severe pain and allodynia (pain that results from a...

2014-02-20 16:24:56

NEWARK, Calif., Feb. 20, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the 2014 RBC Capital Markets' Healthcare Conference at The New York Palace Hotel in New York City. The presentation at the RBC conference is scheduled for 2:05 pm EST (11:05 am PST) on Wednesday, February 26, 2014. Depomed will also be presenting at the Cowen 34(th) Annual Healthcare Conference at the Boston Marriott Copley Place Hotel in Boston at 8:40 am EST...

2014-02-05 04:20:49

MELBOURNE, Australia, February 5, 2014 /PRNewswire/ -- - Phase 2 trial met its primary endpoint, reduced pain in postherpetic neuralgia (PHN) versus placebo - Significant patient response to EMA401 treatment and drop in pain intensity compared with placebo, meeting a key secondary endpoint - First published demonstration of the therapeutic potential of angiotensin II type 2 (AT2)receptor antagonists - EMA401...


Latest Postherpetic neuralgia Reference Libraries

69_7b87211f9314eacab994d465558a3a1b
2011-01-24 12:56:26

Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...

More Articles (1 articles) »
Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'